Efficacy and safety of olaparib in relapsed and refractory chronic lymphocytic leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patients with T-prolymphocytic leukaemia and mantle cell lymphoma

2012 ◽  
Author(s):  
Guy Pratt
2010 ◽  
Vol 123 (3) ◽  
pp. 194-196 ◽  
Author(s):  
Juanah Addada ◽  
Parameswaran Anoop ◽  
John G. Swansbury ◽  
Andy Wotherspoon ◽  
J. Meirion Thomas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document